Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report.
Shan-Wen Lui, Jeng-Wei Lu, Yi-Jung Ho, Shih-En Tang, Kai-Hsiung Ko, Ting-Yu Hsieh, Feng-Cheng Liu · In vivo (Athens, Greece) · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In Some patients do not respond to standard therapeutic interventions, on the fourth day of hydrogen-assisted therapy, a noticeable improvement in lung infiltrations was observed in chest X-rays as the patient gradually progressed towards weaning off mechanical ventilation.
What the Researchers Studied
Some patients do not respond to standard therapeutic interventions.
What the Researchers Found
On the fourth day of hydrogen-assisted therapy, a noticeable improvement in lung infiltrations was observed in chest X-rays as the patient gradually progressed towards weaning off mechanical ventilation.
Authors’ Conclusion
The authors concluded that this case study highlights the effectiveness of hydrogen-assisted therapy in managing PF-ILD complicated by pneumonia, warranting further research in the future.